This has led to the hope that similar products may be developed for hMPV, and Moderna has recently started trials into a mRNA hMPV vaccine. There are no treatments that have been clearly demonstrated ...

Last summer, scientists at the University of Oxford launched a clinical trial of a combined RSV and hMPV vaccine in partnership with Moderna, and Andrew Pollard, a professor of infection and ...

Moderna (NASDAQ:MRNA – Free Report) had its price objective decreased by Evercore ISI from $60.00 to $50.00 in a research ...

Kashmir's leading scientist and gastroenterologist, Prof M Sultran Khuroo writes about the evolution of the Human ...

Most children have had HMPV by the time they reach the age of ... There’s currently no cure or vaccine for the disease, though Moderna, the maker of a COVID-19 vaccine, is working to produce ...

Another Moderna vaccine, mRNA-1653, simultaneously targets human metapneumovirus (HMPV) and parainfluenza virus (PIV3). These viruses typically cause mild respiratory illness, but symptoms can ...

Human metapneumovirus (HMPV) is a commonly found virus that can cause respiratory illness. Although it typically has no symptoms in healthy people, it can cause serious sickness in older adults, those ...

According to the NAID, Moderna, the manufacturer of the Covid-19 vaccine, has just ended an early trial of an mRNA vaccine against HMPV and parainfluenza. According to respiratory virus ...

Research analysts at Leerink Partnrs issued their Q4 2025 earnings estimates for Moderna in a research note issued to ...